Maven Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.67M Sell
15,000
-34,400
-70% -$8.01M 0.07% 205
2025
Q4
$10.2M Buy
49,400
+17,900
+57% +$3.54M 0.23% 108
2025
Q3
$5.84M Buy
31,500
+23,900
+314% +$4.09M 0.14% 153
2025
Q2
$1.16M Sell
7,600
-65,700
-90% -$10.1M 0.03% 405
2025
Q1
$12.2M Buy
+73,300
New +$11.5M 0.37% 62
2024
Q1
Sell
-3,500
Closed -$549K 679
2023
Q4
$549K Sell
3,500
-28,700
-89% -$4.4M 0.01% 638
2023
Q3
$5.02M Sell
32,200
-12,700
-28% -$2.1M 0.06% 193
2023
Q2
$7.43M Buy
44,900
+18,200
+68% +$2.94M 0.11% 98
2023
Q1
$4.14M Sell
26,700
-9,800
-27% -$1.58M 0.09% 152
2022
Q4
$6.48M Sell
36,500
-4,500
-11% -$777K 0.15% 78
2022
Q3
$6.7M Sell
41,000
-3,300
-7% -$558K 0.12% 89
2022
Q2
$7.86M Buy
44,300
+16,900
+62% +$3.01M 0.24% 74
2022
Q1
$4.86M Buy
27,400
+22,300
+437% +$3.79M 0.17% 86
2021
Q4
$872K Sell
5,100
-4,700
-48% -$769K 0.02% 391
2021
Q3
$1.58M Buy
+9,800
New +$1.67M 0.05% 302
2020
Q3
Sell
-7,300
Closed -$1.03M 681
2020
Q2
$1.03M Sell
7,300
-10,800
-60% -$1.57M 0.07% 211
2020
Q1
$2.37M Buy
18,100
+9,900
+121% +$1.4M 0.28% 47
2019
Q4
$1.2M Buy
+8,200
New +$1.11M 0.11% 150

Other funds holding JNJ

Maven Securities's JNJ Position: Q1 2026 in Review

Maven Securities sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 18,046 shares — an estimated $4.2M sold.

Maven Securities first reported a position in JNJ in Q4 2018 and held it in 21 quarters. The position peaked at $5.07M in Q3 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Maven Securities reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Maven Securities sold 18,046 Johnson & Johnson shares in Q1 2026, an estimated $4.2M.
  • Maven Securities first reported a position in Johnson & Johnson in Q4 2018 and held it in 21 quarters.
  • Maven Securities's Johnson & Johnson position peaked at $5.07M in Q3 2023.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.